, Volume 21, Issue 2, pp 108–115 | Cite as

HLA-D and -DR antigens in genetic analysis of insulin dependent diabetes mellitus

  • P. Platz
  • B. K. Jakobsen
  • N. Morling
  • L. P. Ryder
  • A. Svejgaard
  • M. Thomsen
  • M. Christy
  • H. Kromann
  • J. Benn
  • J. Nerup
  • A. Green
  • M. Hauge


Three groups of patients with insulin-dependent diabetes mellitus, ascertained by different procedures, were investigated for HLA-A, B, C and D antigens (n=164), and a subset (n=93) for HLA-DR. Both HLA-D/DR3 and D/DR4 were strongly positively associated and D/DR2 was negatively associated with insulin-dependent diabetes. HLA-DR4 was found to be a better marker for insulin-dependent diabetes than Dw4. The HLA-B associations (B8, B15 and B18) were clearly secondary to the increases of HLA-D/DR3 and D/DR 4. The HLA associations did not differ between familial and isolated cases indicating that these two groups may well have a common genetic background. Based on analysis of HLA-haplotype sharing in affected sibling pairs, a simple dominant model of inheritance could be ruled out, and a simple recessive model was found unlikely. The relative risks for the HLA-Dw3,4 and HLA-DR3,4 phenotype were 21.2 and 44.4 respectively and exceeded those of both the HLA-Dw3 and HLA-DR3 (5.6 and 4.3) as well as the HLA-Dw4 and DR4 (10.1 and 10.5) phenotypes. This argues against an intermediate genetic model but further studies are needed to clarify whether there is more than one susceptibility gene for insulin-dependent diabetes mellitus within the HLA-system.


HLA genetics heterogeneity of insulin-dependent diabetes 


  1. 1.
    Barbosa J, King R, Noreen H, Yunis EJ (1977) The histocompatibility system in juvenile insulin-dependent diabetic multiple kindreds. J Clin Invest 60: 989–998Google Scholar
  2. 2.
    Bengsch N, Köbberling J, Eckert G, Willms B (1978) HLA-typing in juvenile diabetics with and without positive family history and in families with one and two diabetic siblings. Diabetologia 15: 447–451Google Scholar
  3. 3.
    Cavalli-Sforza LL, Bodmer WF (1971) In: The genetics of human populations. WH Freeman and Company, San Francisco, p 45–62Google Scholar
  4. 4.
    Christau B, Kromann H, Christy M, Andersen OO, Nerup J (1979) Incidence of insulin-dependent diabetes mellitus (0–29 years at onset) in Denmark. Acta Med Scand [Suppl] 624: 54–60Google Scholar
  5. 5.
    Christy M, Green A, Christau B, Kromann H, Nerup J, Platz P, Thomsen M, Ryder LP, Svejgaard A (1979) Studies of the HLA system and insulin-dependent diabetes mellitus. Diabetes Care 2: 209–214Google Scholar
  6. 6.
    Cudworth AG (1978) Type I diabetes mellitus. Diabetologia 14: 281–291Google Scholar
  7. 7.
    Cudworth AG, Festenstein H (1978) HLA genetic heterogeneity in diabetes mellitus. Br Med Bull 34: 285–289Google Scholar
  8. 8.
    Day NE, Simons MJ (1976) Disease susceptibility genes — their identification by multiple case family studies. Tissue Antigens 8: 109–119Google Scholar
  9. 9.
    Degnbol B, Green A (1978) Diabetes mellitus among first and second degree relatives of early onset diabetics. Ann Hum Genet 42: 25–47Google Scholar
  10. 10.
    Green A, Hauge M, Holm NV, Rasch LL (1981) Epidemiological studies of diabetes mellitus in Denmark: II. A prevalence study based on insulin prescriptions. Diabetologia 20: 468–470Google Scholar
  11. 11.
    Histocompatibility Testing 1977 (1978) In: Bodmer WF, Batchelor JR, Bodmer JG, Festenstein H, Morris PJ (eds) Histocompatibility testing. Munksgaard, Copenhagen, p 1–612Google Scholar
  12. 12.
    Histocompatibility Testing 1980 (1980) In: Terasaki PI (ed) Histocompatibility testing UCLA, Los Angeles, CaliforniaGoogle Scholar
  13. 13.
    Keuning JJ, Peña AS, van Hooff JP, van Leeuwen A, van Rood JJ (1976) HLA-Dw3 associated with coeliac disease. Lancet I: 506Google Scholar
  14. 14.
    Kissmeyer-Nielsen F, Kjerbye KE (1967) Lymphocytotoxic microtechnique. Purification of lymphocytes by flotation. In: Curtoni ES, Mattiuz PL, Tosi RM (eds) Histocompatibility testing. Munksgaard, Copenhagen, p 381–383Google Scholar
  15. 15.
    Lamm LU, Kristensen T, Jørgensen F, Kissmeyer-Nielsen F (1977) Serological and cellular HLA-determinants — A panel study. Tissue Antigens 10: 138Google Scholar
  16. 16.
    Morling N, Jakobsen BK, Platz P, Ryder LP, Svejgaard A, Thomsen M (1980) Typing for HLA-D/DR associated DP-antigens with the primed lymphocyte typing (PLT) technique. Tissue Antigens 15: 471–482Google Scholar
  17. 17.
    Morling N, Jakobsen BK, Platz P, Ryder LP, Svejgaard A, Thomsen M (1981) Correlations between HLA-D/DR associated primed lymphocyte typing (PLT) defined DP-antigens, HLA-D and HLA-DR antigens. Tissue Antigens (in press)Google Scholar
  18. 18.
    Mouzon A de, Ohayon E, Ducos J, Hauptmann G (1979) Bf and C4 markers for insulin-dependent diabetes in Basques. Lancet II: 1364Google Scholar
  19. 19.
    National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057Google Scholar
  20. 20.
    Nerup J, Platz P, Andersen OO, Christy M, Lyngsøe J, Poulsen JE, Ryder LP, Nielsen LS, Thomsen M, Svejgaard A (1974) HL-A antigens and diabetes mellitus. Lancet II: 864–866Google Scholar
  21. 21.
    Nerup J, Platz P, Ryder LP, Thomsen M, Svejgaard A (1978) HLA, islet cell antibodies, and types of diabetes mellitus. Diabetes 27: 247–250Google Scholar
  22. 22.
    Rubinstein P, Suciu-Foca N, Nicholson JF (1977) Genetics of juvenile diabetes mellitus. N. Engl J Med 297: 1036–1040Google Scholar
  23. 23.
    Ryder LP, Andersen E, Svejgaard A (1979) HLA and disease registry. Third report. Munksgaard, CopenhagenGoogle Scholar
  24. 24.
    Ryder LP, Christy M, Nerup J, Platz P, Svejgaard A, Thomsen M (1979) HLA studies in diabetics. In: Camerini-Davalos RA, Hanover B (eds) Treatment of early diabetes. Plenum Press, New York, p 41–48Google Scholar
  25. 25.
    Sachs JA, Cudworth AG, Jaraquemada D, Gorsuch AN, Festenstein H (1980) Type I diabetes and the HLA-D locus. Diabetologia 18: 41–43Google Scholar
  26. 26.
    Singal DP, Blajchman MA (1973) Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes 22: 429–432Google Scholar
  27. 27.
    Spielman RS, Baker L, Zmijewski CM (1979) Inheritance of susceptibility to juvenile onset diabetes. In: Sing CF, Skolnick M (eds) Genetic analysis of common diseases: Applications to predictive factors in coronary disease. Liss, New York, p 567–585Google Scholar
  28. 28.
    Spielman RS, Baker L, Zmijewski CM (1981) Gene dosage and susceptibility to insulin-dependent diabetes. Ann Hum Genet 44: 135–150Google Scholar
  29. 29.
    Svejgaard A, Platz P, Ryder LP, Nielsen LS, Thomsen M (1975) HL-A and disease associations — A survey. Transplant Rev 22: 3–43Google Scholar
  30. 30.
    Svejgaard A, Christy M, Nerup J, Platz P, Ryder LP, Thomsen M (1978) HLA and autoimmune disease with special reference to the genetics of insulin-dependent diabetes. In: Rose NR, Bigazzi PE, Warner NL (eds) Genetic control of autoimmune disease. Elsevier, North Holland, New York, p 101–112Google Scholar
  31. 31.
    Svejgaard A, Hauge M, Jersild C, Platz P, Ryder LP, Staub Nielsen L, Thomsen M (1979) The HLA system. An introductory survey. In: Beckman L, Hauge M (eds) Monographs in human genetics. Karger, BaselGoogle Scholar
  32. 32.
    Svejgaard A, Platz P, Ryder LP (1980) Insulin-dependent diabetes mellitus. In: Terasaki PI (ed) Histocompatibility testing 1980. UCLA, Los Angeles, California, p 638–656Google Scholar
  33. 33.
    Thomsen M, Hansen GS, Svejgaard A, Jersild C, Hansen JA, Good RA, Dupont B (1974) Mixed lymphocyte culture technique. Tissue Antigens 4: 495–506Google Scholar
  34. 34.
    Thomsen M, Jakobsen BK, Platz P, Ryder LP, Staub Nielsen L, Svejgaard A (1975) LD-typing, polymorphism of MLC determinants. In: Kissmeyer-Nielsen F (ed) Histocompatibility testing 1975. Munksgaard, Copenhagen, p 509–518Google Scholar
  35. 35.
    Thomsen M, Platz P, Andersen OO, Christy M, Lyngsøe J, Nerup J, Rasmussen K, Ryder LP, Staub Nielsen L, Svejgaard A (1975) MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease. Transplant Rev 22: 125–147Google Scholar
  36. 36.
    Thomsen M, Nerup J, Christy M, Andersen OO, Kromann H, Platz P, Ryder LP, Svejgaard A (1980) HLA antigens and diabetes. In: Burman D, Holton JB, Pennock CA (eds) Inherited disorders of carbohydrate metabolism. MTP Press, Lancaster, p 401–409Google Scholar
  37. 37.
    Thomson G, Bodmer WF (1977) The genetics of HLA and disease association. In: Barndorff-Nielsen O, Christiansen FB, Fenchel T (eds) Measuring selection in natural populations. Munksgaard, Copenhagen, pp 545–563Google Scholar
  38. 38.
    Thomson G, Bodmer WF (1979) HLA haplotype associations with disease. Tissue Antigens 13: 91–102Google Scholar
  39. 39.
    Svejgaard A, Ryder LP (1981) HLA genotype distribution and genetic models of insulin-dependent diabetes mellitus. Ann Hum Genet (in press)Google Scholar

Copyright information

© Springer-Verlag 1981

Authors and Affiliations

  • P. Platz
    • 1
  • B. K. Jakobsen
    • 1
  • N. Morling
    • 1
  • L. P. Ryder
    • 1
  • A. Svejgaard
    • 1
  • M. Thomsen
    • 1
  • M. Christy
    • 2
  • H. Kromann
    • 2
  • J. Benn
    • 2
  • J. Nerup
    • 2
  • A. Green
    • 3
  • M. Hauge
    • 3
  1. 1.Tissue Typing Laboratory of the Blood Grouping DepartmentUniversity Hospital (Rigshospitalet)CopenhagenDenmark
  2. 2.Steno Memorial HospitalGentofteDenmark
  3. 3.Institute of Clinical GeneticsUniversity of OdenseDenmark

Personalised recommendations